Estados financieros detallados de Aprea Therapeutics, Inc. (APRE): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $0.73, APRE presenta beneficios negativos (P/E no significativo) y un ROE del -101.27%. La capitalización bursátil es de $9M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | $583231 | $1.5M | 0 |
| Coste de Ventas | $7932 | $8316 | $170254 | $229610 | $271677 | $16.4M | $7052 | $9.4M | 0 |
| Beneficio Bruto | -$7932 | -$8316 | -$170254 | -$229610 | -$271677 | -$16.4M | $576179 | -$7.9M | 0 |
| I+D | $13.4M | $14.2M | $21.0M | $37.9M | $23.9M | $92.4M | $7.6M | $9.4M | $7.0M |
| Generales y Administrativos | $2.5M | $2.3M | $8.4M | $14.9M | $13.6M | $21.0M | $8.4M | $6.5M | $6.5M |
| Gastos Operativos | $15.9M | $16.5M | $29.4M | $52.8M | $37.2M | $97.0M | $16.0M | $6.5M | $13.2M |
| Beneficio Operativo | -$15.9M | -$16.5M | -$29.5M | -$52.8M | -$37.4M | -$113.4M | -$15.5M | -$14.3M | -$13.2M |
| EBITDA | -$15.2M | -$15.5M | -$27.9M | -$53.2M | -$36.9M | -$37.4M | -$14.3M | -$12.9M | -$12.6M |
| Gastos por Intereses | $15 | $182 | $156351 | $222652 | 0 | $448667 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$15.2M | -$15.5M | -$28.1M | -$53.5M | -$37.1M | -$112.7M | -$14.3M | -$13.0M | -$12.6M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$15.2M | -$15.5M | -$28.1M | -$53.9M | -$36.5M | -$112.7M | -$14.3M | -$13.0M | -$12.6M |
| BPA | $-21.58 | $-22.06 | $-26.28 | $-50.61 | $-34.88 | $-1359.79 | $-3.95 | $-2.35 | $-1.93 |
| BPA Diluido | $-21.58 | $-22.06 | $-26.28 | $-50.61 | $-34.88 | $-1359.79 | $-3.95 | $-2.35 | $-1.93 |
| Acciones en Circulación (Diluidas) | $703783 | $703783 | $1.0M | $1.1M | $1.1M | $82852 | $3.6M | $5.5M | $6.5M |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $24.4M | $65.7M | $130.1M | $89.0M | $53.1M | $28.8M | $21.6M | $22.8M | $14.6M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $24.7M | $66.0M | $133.0M | $92.4M | $56.6M | $30.2M | $22.5M | $23.6M | $15.6M |
| Inmovilizado Material | $30336 | $24450 | $563031 | $359131 | $209681 | $2321 | $88362 | $81522 | $59807 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $24.8M | $66.0M | $133.6M | $92.8M | $56.8M | $30.2M | $22.7M | $24.0M | $15.9M |
| Cuentas por Pagar | $1.7M | $1.7M | $2.2M | $4.5M | $1.8M | $842754 | $1.7M | $1.4M | $713668 |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $4.3M | $4.9M | $9.1M | $15.3M | $7.3M | $3.2M | $4.4M | $3.4M | $2.8M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $60.5M | $117.5M | $9.4M | $15.4M | $7.3M | $4.5M | $4.4M | $4.7M | $3.5M |
| Reservas | -$46.9M | -$62.5M | -$90.5M | -$144.0M | -$181.1M | -$293.8M | -$308.1M | -$321.0M | -$333.6M |
| Patrimonio Neto | -$35.8M | -$51.4M | $124.2M | $77.4M | $49.5M | $25.6M | $18.3M | $19.3M | $12.4M |
| Deuda Total | 0 | 0 | $544950 | $335156 | $190471 | 0 | 0 | 0 | 0 |
| Deuda Neta | -$24.4M | -$65.7M | -$129.5M | -$88.7M | -$52.9M | -$28.8M | -$21.6M | -$22.8M | -$14.6M |
| Capital Circulante | $20.4M | $61.1M | $124.0M | $77.1M | $49.3M | $27.0M | $18.1M | $20.2M | $12.8M |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$15.2M | -$15.5M | -$28.1M | -$53.5M | -$37.1M | -$112.7M | -$14.3M | -$13.0M | -$12.6M |
| Amortizaciones | $7932 | $8316 | $170254 | $229610 | $271677 | $186445 | $7052 | $22318 | $21715 |
| Compensación en Acciones | $395440 | $329184 | $1.3M | $5.0M | $7.8M | $17.0M | $444459 | $489436 | $478141 |
| Cambio en Capital Circulante | $1.4M | $901851 | $1.2M | $5.6M | -$8.3M | -$1.8M | $1.6M | -$1.1M | -$929095 |
| Flujo de Caja Operativo | -$14.0M | -$15.3M | -$26.7M | -$41.8M | -$37.7M | -$25.0M | -$12.2M | -$13.6M | -$12.9M |
| Inversiones (CapEx) | 0 | -$3702 | -$30901 | -$25709 | 0 | 0 | -$93093 | -$15478 | 0 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$14.0M | -$15.3M | -$26.7M | -$41.8M | -$37.7M | -$25.0M | -$12.3M | -$13.6M | -$12.9M |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +157.6% | -100.0% | |||||||
| Crecimiento Beneficio Neto (anual) | -2.2% | -80.7% | -92.1% | +32.2% | -208.4% | +87.3% | +9.3% | +2.8% | |
| Crecimiento BPA (anual) | -2.2% | -19.1% | -92.6% | +31.1% | -3798.5% | +99.7% | +40.5% | +17.9% | |
| Cambio en Acciones (anual) | +0.0% | +42.8% | +5.2% | +0.7% | -92.2% | +4266.3% | +52.3% | +18.7% | |
| Crecimiento FCF (anual) | -8.9% | -75.3% | -56.4% | +9.9% | +33.6% | +50.9% | -10.6% | +5.0% | |
| Margen Bruto | 98.8% | -523.2% | |||||||
| Margen Operativo | -2652.8% | -953.0% | |||||||
| Margen EBITDA | -2448.4% | -860.9% | |||||||
| Margen Neto | -2449.6% | -862.4% | |||||||
| Margen FCF | -2103.9% | -903.3% | |||||||
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-19.90 | $-21.67 | $-26.61 | $-39.58 | $-35.41 | $-301.88 | $-3.39 | $-2.46 | $-1.97 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $703783 | $703783 | $1.0M | $1.1M | $1.1M | $82852 | $3.6M | $5.5M | $6.5M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -101.27% |
| Rentabilidad sobre capital invertido | -100.49% |
| Rentabilidad sobre activos | -79.08% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 5.63 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| P/E | -19.00 | -18.59 | -34.92 | -1.94 | -1.65 | -0.00 | -1.19 | -1.40 | -0.44 |
| P/VC | -8.07 | -5.61 | 7.42 | 1.34 | 1.23 | 0.02 | 0.93 | 0.94 | 0.45 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 29.15 | 12.06 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 98.8% | -523.2% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -2652.8% | -953.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -2449.6% | -862.4% | 0.0% |
Empresas relacionadas: ACXP · ADIL · APVO · BCDA · CELZ · GLTO · HCWB
Explorar sector: Healthcare · Biotechnology
Más secciones de APRE: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones